Cardiometabolic Modification of Amyloid Beta in Alzheimer’s Disease Pathology

In recent years, several studies have suggested that cardiometabolic disorders, such as diabetes, obesity, hypertension, and dyslipidemia, share strong connections with the onset of neurodegenerative disorders such as Parkinson’s and Alzheimer’s disease (AD). However, establishing a definitive link...

Descripción completa

Detalles Bibliográficos
Autores principales: Hefner, Marleigh, Baliga, Vineet, Amphay, Kailinn, Ramos, Daniela, Hegde, Vijay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8419421/
https://www.ncbi.nlm.nih.gov/pubmed/34497507
http://dx.doi.org/10.3389/fnagi.2021.721858

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8419421/
https://www.ncbi.nlm.nih.gov/pubmed/34497507
http://dx.doi.org/10.3389/fnagi.2021.721858

Ejemplares similares